Cargando…

Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors

Bisphenol A (BPA) is used as an industrial raw material for polycarbonate plastics and epoxy resins; however, various concerns have been reported regarding its status as an endocrine-disrupting chemical. BPA interacts not only with oestrogen receptors (ERs) but constitutive androstane receptor, preg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuya, Takahiro, Iwamoto, Masaki, Liu, Xiaohui, Matsushima, Ayami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616570/ https://www.ncbi.nlm.nih.gov/pubmed/31289329 http://dx.doi.org/10.1038/s41598-019-46272-y

Ejemplares similares

Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ
por: Matsushima, Ayami, et al.
Publicado: (2010)

Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)α agonist and unaffected by an ERβ antagonist
por: Jeanes, Helen L, et al.
Publicado: (2008)

Privileged Structures Revisited
por: Schneider, Petra, et al.
Publicado: (2017)

Bisphenol A derivatives act as novel coactivator-binding inhibitors for estrogen receptor β
por: Iwamoto, Masaki, et al.
Publicado: (2021)

Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery
por: Khwaza, Vuyolwethu, et al.
Publicado: (2021)

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
por: Osborne, C K, et al.
Publicado: (2004)

A Characteristic Back Support Structure in the Bisphenol A-Binding Pocket in the Human Nuclear Receptor ERRγ
por: Liu, Xiaohui, et al.
Publicado: (2014)

Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016)

Nuclear and cytoplasmic oestrogen receptors in squamous carcinoma of the cervix.
por: Soutter, W. P., et al.
Publicado: (1981)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists
por: Mishra, Rama K., et al.
Publicado: (2016)

Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro
por: Al-Khyatt, Waleed, et al.
Publicado: (2018)

Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H(3) receptor antagonists/inverse agonists containing triazole moiety
por: Song, Mingxia, et al.
Publicado: (2020)

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
por: Lagarde, Nathalie, et al.
Publicado: (2016)

Of Oestrogens and Sperm: A Review of the Roles of Oestrogens and Oestrogen Receptors in Male Reproduction
por: Dostalova, Pavla, et al.
Publicado: (2017)

Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)

In vitro assessment of pesticides capacity to act as agonists/antagonists of the thyroid hormone nuclear receptors
por: Zekri, Yanis, et al.
Publicado: (2021)

In vitro assessment of pesticides capacity to act as agonists/antagonists of the thyroid hormone nuclear receptors
por: Zekri, Yanis, et al.
Publicado: (2021)

Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)

Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor.
por: Piva, R., et al.
Publicado: (1990)

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2021)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Oestrogen and androgen receptors in melanoma.
por: Rümke, P., et al.
Publicado: (1980)

Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications
por: Yaghmaei, Sepideh, et al.
Publicado: (2013)

Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis.
por: Leake, R. E., et al.
Publicado: (1981)

Small Molecules Incorporating Privileged Amidine Moiety as Potential Hits Combating Antibiotic-Resistant Bacteria
por: El-Sayed, Selwan M., et al.
Publicado: (2023)

Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1
por: Luo, Ling, et al.
Publicado: (2013)

Conformational dynamics of androgen receptors bound to agonists and antagonists
por: Gim, Hyo Jin, et al.
Publicado: (2021)

Potent Inhibition of Heterotopic Ossification by Nuclear Retinoic Acid Receptor γ Agonists
por: Shimono, Kengo, et al.
Publicado: (2011)

A de novo substructure generation algorithm for identifying the privileged chemical fragments of liver X receptorβ agonists
por: Peng, He, et al.
Publicado: (2017)

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

Oestrogen receptor alpha in pulmonary hypertension
por: Wright, Audrey F., et al.
Publicado: (2015)

The role of oestrogen and progesterone receptors in gigantomastia
por: Kasielska-Trojan, Anna, et al.
Publicado: (2019)

Complementary yet distinct roles for oestrogen receptor-α and oestrogen receptor-β in mouse mammary epithelial proliferation
por: Clarke, Robert B
Publicado: (2004)

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight
por: Haglund, Felix, et al.
Publicado: (2015)

Identification of New Agonists and Antagonists of the Insect Odorant Receptor Co-Receptor Subunit
por: Chen, Sisi, et al.
Publicado: (2012)

The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
por: Robello, Marco, et al.
Publicado: (2021)

Discovery of GPR183 Agonists Based on an Antagonist Scaffold
por: Kjær, Viktoria M. S., et al.
Publicado: (2021)

Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1
por: Lim, Kheng Tian, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_75cf0im5n8pcn7frmtve696cv8